ArticleInternational journal of hematology2022

Response to blinatumomab or inotuzumab ozogamicin for isolated extramedullary relapse of adult acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation: a case study.

Seung-Hwan Lee et al.PubMed ↗Publisher ↗

No numbers read from the abstract.